CCND1 |
−3.1#
|
−1.1 |
cyclin D1 |
CCND2 |
−3.1 |
−3.3 |
cyclin D2 |
CDK4 |
−1.3 |
−2.2 |
cyclin-dependent kinase 4 |
CDK6 |
−1.8 |
−1.1 |
cyclin-dependent kinase 6 |
CDKN1A |
2.2 |
1.0 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
CHEK2 |
−1.2 |
−1.9 |
CHK2 checkpoint homolog (S. pombe) |
GNL3 |
−2.0 |
−2.1 |
guanine nucleotide binding protein-like 3 (nucleolar) |
H1F0 |
3.8 |
2.4 |
H1 histone family, member 0 |
HERC5 |
2.2 |
1.9 |
hect domain and RLD 5 |
HEXIM1 |
2.3 |
1.3 |
hexamethylene bis-acetamide inducible 1 |
HSPA2 |
2.8 |
2.3 |
heat shock 70kDa protein 2 |
IFITM1 |
5.0 |
1.8 |
interferon induced transmembrane protein 1 |
LMLN |
1.9 |
2.2 |
leishmanolysin-like, metallopeptidase M8 family |
MYC |
−3.0 |
−4.5 |
v-myc myelocytomatosis viral oncogene homolog |
NEFH |
6.6 |
1.3 |
neurofilament, heavy polypeptide |
NEFL |
−2.3 |
−3.1 |
neurofilament, light polypeptide |
NOLC1 |
−1.8 |
−2.4 |
nucleolar and coiled-body phosphoprotein 1 |
PTTG2 |
1.1 |
2.0 |
pituitary tumor-transforming 2 |
RRS1 |
−2.6 |
−2.5 |
RRS1 ribosome biogenesis regulator |
SFN |
14.3 |
1.6 |
stratifin (14-3-3σ) |
TGFB2 |
−2.1 |
−1.3 |
transforming growth factor, beta 2 |
FASN##
|
2.2 |
2.2 |
fatty acid synthase |
MERTK##
|
8.3 |
21.5 |
c-mer proto-oncogene tyrosine kinase |